TDACW NASDAQ
Translational Development Acquisition Corp.
1W: -8.5%
1M: -15.2%
3M: -2.1%
YTD: +351.6%
$1.40
-0.05 (-3.45%)
Weekly Expected Move ±12.3%
$1
$1
$1
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$209.8M
52W Range0.06-2.8
Volume1,246
Avg Volume57,849
Beta2.11
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael Hoffman
Employees2
SectorFinancial Services
IndustryShell Companies
IPO Date2025-06-16
52 E. 83rd Street
New York City, NY 10028
US
New York City, NY 10028
US
917 979 3072
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Jarratt Christopher | 0 | — | 2024-12-20 | |
| Keith Curtis T | 0 | — | 2024-12-20 | |
| TDAC Partners LLC | 4,657,500 | — | 2024-12-20 | |
| Reddy E Premkumar | 0 | — | 2024-12-20 | |
| Kestenbaum Matthew | 0 | — | 2024-12-20 |